Background Although topical minoxidil is an effective treatment option for hair loss, many
patients are poorly compliant because of the necessity to apply the medication twice a day …

Abstract Topical minoxidil (5% foam, 5% solution, and 2% solution) is FDA-approved for
androgenetic alopecia (AGA) in men and women. Mechanism of action: Minoxidil acts …

Androgenetic alopecia is the most common hair loss disorder, affecting both men and
women. Initial signs of androgenetic alopecia usually develop during teenage years leading …

Introduction Androgenetic alopecia is a common hair loss disorder affecting up to 80% of
males by the age of 80. It is characterized by androgen related progressive thinning of hair …

REFERENCES 1. Ciechanowicz P, Rakowska A, Sikora M, Rudnicka L. JAK-inhibitors in
dermatology. Current evidence and future applications. J Dermatol Treat. 2018: 1-22. 2 …

Hair is a deeply rooted component of identity and culture. Recent articles in this series have
focused on scientific evidence relating to hair growth and new insights into the pathogenesis …

Considering the different forms, alopecia could be a very common condition with particular
therapeutic concerns; thus, recent therapies still require further assessments. Aim of this …

Androgenetic alopecia (AGA) is the most common nonscarring alopecia and is
characterised by distinct gradual patterned hair loss. AGA is mediated by genetic …

Male androgenetic alopecia is a common condition and represents a major concern for
patients who experience this condition. While there are different treatments to stop hair loss …

Abstract low dose oral minoxidil (OM) is an increasingly used treatment for androgenetic
alopecia and other types of hair loss. to analyze available data of patients treated with OM …